Newtown, PA, United States of America

Sylvia J Degrado

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Polytherics Limited. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sylvia J Degrado. Retrieved from https://idiyas.com/inventor/sylvia-j-degrado

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Sylvia J. Degrado: Pioneering Advances in Cytotoxic Agents

Introduction: Sylvia J. Degrado, an accomplished inventor based in Newtown, PA, has made significant contributions to the field of pharmaceuticals through her innovative work on cytotoxic agents. With one patent to her name, she has focused on developing novel compounds that hold promise in cancer therapy.

Latest Patents: Sylvia's patent, titled "Cytotoxic agents and conjugates thereof," introduces groundbreaking maytansinoid compounds characterized by a general formula. This innovative patent outlines not only the compounds themselves but also conjugates that link these compounds to binding proteins via a linker. Additionally, the patent describes conjugating reagents that attach the maytansinoid compounds to functional groups capable of reacting with binding proteins. The pharmaceutical compositions resulting from this work are poised to enhance therapeutic methods in cancer treatment, showcasing a novel synthetic process for these valuable compounds.

Career Highlights: As a key inventor at Polytherics Limited, Sylvia Degrado has focused her efforts on advancing medical science through targeted therapies. Her pioneering work in creating conjugates and therapeutic methods showcases her commitment to addressing challenging medical conditions, particularly cancer.

Collaborations: In her professional journey, Sylvia has collaborated with notable colleagues, including Nareshkumar Jain and Sanjeevani Ghone. Their teamwork exemplifies the importance of collaboration in the innovation process, allowing for the fusion of diverse ideas and expertise to push boundaries in research and development.

Conclusion: Sylvia J. Degrado stands as a prominent figure in the field of pharmaceutical innovations, particularly in the realm of cytotoxic agents. Her patent reflects a significant step forward in cancer therapy, and her collaborations highlight the importance of teamwork in driving innovation. As researchers and companies continue to focus on breakthroughs in medical treatments, the work of inventors like Sylvia plays a crucial role in shaping the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…